These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7742441)

  • 1. Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association?
    McAlister F; McClean K; Hamilton PG; Houston S
    Clin Infect Dis; 1995 Feb; 20(2):348-51. PubMed ID: 7742441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyria cutanea tarda in a patient with HIV-infection.
    Almehmi A; Deliri H; Szego GG; Teague AC; Pfister AK; Martin SA
    W V Med J; 2005; 101(1):19-21. PubMed ID: 15861867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital.
    Aguilera P; Laguno M; To-Figueras J
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):93-7. PubMed ID: 26576928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyria cutanea tarda in a HIV- positive patient.
    Franzon VA; Mikilita ES; Camelo FH; Camargo R
    An Bras Dermatol; 2016; 91(4):520-3. PubMed ID: 27579753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C.
    Rich JD; Mylonakis E; Nossa R; Chapnick RM
    Dig Dis Sci; 1999 May; 44(5):1034-7. PubMed ID: 10235615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desferrioxamine treatment of porphyria cutanea tarda in a patient with HIV and chronic renal failure.
    Vasconcelos P; Luz-Rodrigues H; Santos C; Filipe P
    Dermatol Ther; 2014; 27(1):16-8. PubMed ID: 24502304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C.
    O'Connor WJ; Badley AD; Dicken CH; Murphy GM
    Mayo Clin Proc; 1998 Sep; 73(9):895-7. PubMed ID: 9737229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Porphyria cutanea tarda and human immunodeficiency virus infection].
    Soriano E; Catalá MT; Lacruz J; Campayo A; López Aldeguer J; Perelló A
    Rev Clin Esp; 1993 Feb; 192(3):120-2. PubMed ID: 8096647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Porphyria cutanea tarda and human immunodeficiency virus infection. Apropos of 2 further cases].
    Belda Mira A; Rovira Daudí E; Díaz Sánchez F; Michavila Gómez J
    Rev Clin Esp; 1994 Jul; 194(7):583-4. PubMed ID: 7938832
    [No Abstract]   [Full Text] [Related]  

  • 10. HAART: a risk factor for development of porphyria cutanea tarda?
    Bernardes Filho F; Santos MV; Carvalho FN; Castro CG; Dobao E; Lyra MR; Menezes Vd; Nery JA
    Rev Soc Bras Med Trop; 2012 Dec; 45(6):764-7. PubMed ID: 23295885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
    Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
    Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Porphyria cutanea tarda (type 1) in HIV infection].
    Hoegl L; Thoma-Greber E; Röcken M
    Hautarzt; 1996 Jan; 47(1):58-61. PubMed ID: 8835006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyria cutanea tarda associated with human immunodeficiency virus infection.
    Drobacheff C; Derancourt C; Van Landuyt H; Devred D; de Wazieres B; Cribier B; Rey D; Lang JM; Grosieux C; Kalis B; Laurent R
    Eur J Dermatol; 1998; 8(7):492-6. PubMed ID: 9854161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda in association with human immunodeficiency virus infection: it is related to hepatitis C virus infection?
    Castanet J; Lacour JP; Bodokh J; Bekri S; Ortonne JP
    Arch Dermatol; 1994 May; 130(5):664-5. PubMed ID: 7910010
    [No Abstract]   [Full Text] [Related]  

  • 15. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
    Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous pigmentation, only manifestation of porphyria cutanea tarda in a HIV-1 positive patient].
    Pascual C; García-Patos V; Bartralot R; Pedragosa R; Capdevila M; Barberá J; Castells A
    Ann Dermatol Venereol; 1996; 123(4):262-4. PubMed ID: 8763751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Porphyria cutanea tarda and HIV-1 infection. 2 new cases].
    el Sayed F; Viraben R; Bazex J; Gorguet B
    Ann Dermatol Venereol; 1993; 120(6-7):455-7. PubMed ID: 7904142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyria cutanea tarda and HIV/AIDS: a review of pathogenesis, clinical manifestations and management.
    Mansourati FF; Stone VE; Mayer KH
    Int J STD AIDS; 1999 Jan; 10(1):51-6. PubMed ID: 10215132
    [No Abstract]   [Full Text] [Related]  

  • 19. Porphyria cutanea tarda and human immunodeficiency virus infection.
    Blauvelt A; Harris HR; Hogan DJ; Jimenez-Acosta F; Ponce I; Pardo RJ
    Int J Dermatol; 1992 Jul; 31(7):474-9. PubMed ID: 1500237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of lupus erythematosus and porphyria cutanea tarda in fifteen patients.
    Gibson GE; McEvoy MT
    J Am Acad Dermatol; 1998 Apr; 38(4):569-73. PubMed ID: 9555796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.